FindTrial
Sign In

Evaluation of usefulness of M2BPGi as a predictive indicator of atherosclerosis

A cross-sectional study to evaluate the usefulness of M2BPGi as a diagnostic indicator of atherosclerosis in atherosclerotic subjects diagnosed by ultrasound during medical examination.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004713
Enrollment
270
Registered
2020-02-07
Start date
2020-02-03
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Seoul Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We will use medical records from March 1, 2019 to May 31, 2019 for those who performed health check-ups including carotid artery sonography at Hanyang University Medical Center.

Exclusion criteria

Exclusion criteria: 1) Foreigner 2) Missing data for skeletal muscle, sonography or alcohol consumption 3) Viral hepatitis positive or chronic liver disease 4) Alcohol consumption (>210 g for men and >140 g for women 5) Person who take a medication causing fatty liver such as steoid

Design outcomes

Primary

MeasureTime frame
Mean analysis of serum M2BPGi according to the severity of atherosclerosis—

Secondary

MeasureTime frame
The prevalence of advanced atherosclerosis according to M2BPGi—

Countries

Korea, Republic of

Contacts

Public ContactPark yul

Hanyang University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026